Craft

Chr. Hansen

Revenue

€1.2 B

FY, 2022

Chr. Hansen Summary

Company Summary

Overview
Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The products include cultures, enzymes, probiotics and natural colors, and all solutions are based on strong research and development competencies coupled with significant technology investments. Revenue in the 2014/15 financial year was EUR 859 million. The company has more than 2,600 dedicated employees in 30 countries and main production facilities in Denmark, France, USA and Germany. Chr. Hansen was founded in 1874 and is listed on Nasdaq Copenhagen.
Type
Subsidiary
Status
Active
Founded
1874
HQ
Hørsholm, DK | view all locations
Website
https://www.chr-hansen.com/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Mauricio Graber

    Mauricio Graber, President & CEO - Executive Board Member

  • Luis Cantarell

    Luis Cantarell, Board Member

    • Charlotte Hemmingsen

      Charlotte Hemmingsen, Board Member (Employee Representative)

      • Thomas SchaFer

        Thomas SchaFer, Executive Vice President & CSO – Executive Board Member

        LocationsView all

        51 locations detected

        • Hørsholm HQ

          Denmark

          Bøge Alle 10, 12

        • Milwaukee, WI

          United States

          9015 W Maple St

        • New Berlin, WI

          United States

          16300 W Lincoln Ave

        • Windsor, WI

          United States

          4375 Duraform Ln

        • Algiers, Algiers Province

          Algeria

          North Tower East entrance, 4th floor

        • Buenos Aires, CABA

          Argentina

          piso 1107, Cecilia Grierson 422

        and 45 others

        Chr. Hansen Financials

        Summary Financials

        Revenue (FY, 2022)
        €1.2B
        Gross profit (FY, 2022)
        €727.8M
        Net income (FY, 2022)
        €225.1M
        Cash (FY, 2022)
        €82.8M
        EBIT (FY, 2022)
        €312.9M

        Footer menu